Question 1

What are the potential benefits of participating in this trial for my diabetes management?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes clinical trial (NCT06609356). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the SGLT2 inhibitor work, and what side effects should I expect?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes clinical trial (NCT06609356). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the study visits involve, and how often will I need to come in?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes clinical trial (NCT06609356). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any risks associated with the procedures performed during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes clinical trial (NCT06609356). Contact the study team or your healthcare provider for specific answers.

Question 5

How will this trial compare to my current diabetes treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes clinical trial (NCT06609356). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes clinical trial (NCT06609356). Contact the study team or your healthcare provider for specific answers.

What this study is about